Tubo‑ovarian Abscess (TOA)
Overview
A tubo‑ovarian abscess (TOA) is a large, pus‑filled inflammatory mass that forms when an infection spreads to a woman’s fallopian tube and ovary, causing them to become fused together. It most often results from an untreated or partially treated pelvic inflammatory disease (PID), but can also arise after abdominal surgery, tuberculosis, or a ruptured ovarian cyst.
- Who it affects: Women of reproductive age (15‑45 years), especially those with a history of sexually transmitted infections (STIs) or prior PID.
- Prevalence: TOA accounts for about 15‑20 % of all PID hospitalizations in the United States. Annually, an estimated 8–12 women per 100,000 develop a TOA [1][2].
- Impact: If not promptly treated, a TOA can rupture, leading to life‑threatening peritonitis, infertility, or chronic pelvic pain.
Symptoms
Symptoms can develop over days to weeks and may range from mild to severe. The most common manifestations include:
- Pelvic or lower‑abdominal pain: Usually constant, unilateral (one side), and may radiate to the back or thigh.
- Fever & chills: Typically >38 °C (100.4 °F); chills suggest systemic infection.
- Vaginal discharge: Malodorous, sometimes bloody or purulent.
- Urinary symptoms: Frequency, urgency, or dysuria from bladder irritation.
- Gastrointestinal upset: Nausea, vomiting, or loss of appetite.
- Change in menstrual bleeding: Spotting or heavier periods.
- General malaise: Fatigue, muscle aches, or feeling “unwell.”
- Palpable abdominal mass: In large abscesses a firm lump may be felt.
- Signs of sepsis (advanced cases): Rapid heart rate, low blood pressure, confusion.
Causes and Risk Factors
Primary Causes
- Pelvic inflammatory disease (PID): The most common antecedent. Bacterial infection ascends from the cervix to the uterus, tubes, and ovaries.
- Sexually transmitted infections: Neisseria gonorrhoeae and Chlamydia trachomatis account for >50 % of cases.
- Polymicrobial infection: Anaerobes (e.g., Bacteroides spp.), Gram‑negative rods, and facultative organisms often coexist.
- Post‑surgical or post‑procedural infection: After laparoscopic sterilization, hysteroscopy, or ovarian cyst drainage.
- Non‑STI organisms: Tuberculosis, Actinomyces, and other rare pathogens in immunocompromised patients.
Risk Factors
- Multiple sexual partners or inconsistent condom use.
- Previous PID, TOA, or sexually transmitted infection.
- Intrauterine device (IUD) placement, especially within the first 6 weeks.
- History of endometriosis or ovarian cysts.
- Smoking (impairs mucosal immunity).
- Immunosuppression (HIV, diabetes, corticosteroid therapy).
- Recent pelvic surgery or pelvic radiation.
Diagnosis
Clinical Evaluation
Healthcare providers begin with a thorough history and physical exam, focusing on pelvic tenderness, cervical motion tenderness, adnexal (ovary‑tube) swelling, and systemic signs (fever, tachycardia).
Laboratory Tests
- Complete blood count (CBC): Elevated white‑blood‑cell count (>12 × 10⁹/L) suggests infection.
- C‑reactive protein (CRP) & erythrocyte sedimentation rate (ESR): Inflammatory markers are usually high.
- Pregnancy test: To rule out ectopic pregnancy before imaging or invasive procedures.
- Microbiologic studies: Vaginal/cervical swabs for gonorrhea, chlamydia, and anaerobes; blood cultures if sepsis suspected.
Imaging
- Transvaginal ultrasound (TVUS): First‑line; shows a complex, multilocular mass with thick walls and internal echoes indicative of pus. Doppler may reveal peripheral blood flow.
- Computed tomography (CT) scan: Provides detailed anatomy, helps identify rupture or spread to adjacent organs, and is useful when ultrasound is inconclusive.
- Magnetic resonance imaging (MRI): Highly sensitive for differentiating TOA from ovarian malignancy, especially in pregnant patients where radiation is avoided.
Diagnostic Criteria (simplified)
A diagnosis is usually made when a patient has:
- Pelvic pain and fever, and
- Imaging showing a tubo‑ovarian mass >3 cm with central fluid collection, and
- Laboratory evidence of infection (elevated WBC/CRP) or positive culture.
Treatment Options
Medical Management (First‑line)
Broad‑spectrum intravenous antibiotics are initiated promptly, covering both aerobic and anaerobic organisms.
| Antibiotic Regimen (IV) | Typical Duration |
|---|---|
| Ceftriaxone 1 g daily + Doxycycline 100 mg PO/IV q12h + Metronidazole 500 mg PO/IV q8h | 10‑14 days |
| Cefoxitin 2 g IV q6h + Doxycycline 100 mg PO/IV q12h | 10‑14 days |
| Clindamycin 900 mg IV q8h + Gentamicin 5‑7 mg/kg IV q24h (renal dose‑adjusted) | 10‑14 days |
After clinical improvement (afebrile ≥48 h, pain decreasing), patients are switched to oral antibiotics to complete a total of 14‑21 days of therapy.
Surgical/Procedural Management
Surgery is reserved for:
- Failure to improve after 48‑72 h of optimal antibiotics.
- Ruptured abscess or diffuse peritonitis.
- Large abscess (>8–10 cm) or suspicion of malignancy.
Procedures include:
- Laparoscopic drainage: Minimally invasive; catheter placement to evacuate pus while preserving fertility.
- Laparotomy: Open surgery for massive abscesses, ruptures, or when extensive adhesions are present.
- Image‑guided percutaneous drainage: CT or ultrasound‑guided catheter in patients who are poor surgical candidates.
Adjunctive Measures
- Pain control: NSAIDs (ibuprofen 400‑600 mg q6‑8h) or opioid short‑term for severe pain.
- Hydration & electrolyte monitoring: IV fluids to maintain perfusion.
- Fertility counseling: Discuss potential impact on tubal patency; consider referral to a reproductive specialist.
Living with Tubo‑ovarian Abscess
Daily Management Tips
- Medication adherence: Finish the entire antibiotic course, even if you feel better.
- Rest & activity: Limit strenuous activity for 2‑3 weeks; gentle walking promotes circulation.
- Heat therapy: A warm (not hot) compress on the lower abdomen can ease muscular pain.
- Hydration: Aim for ≥2 L of water daily to help the body clear infection.
- Pelvic floor exercises: After the acute phase, Kegel exercises improve pelvic muscle tone and may reduce chronic pain.
- Follow‑up appointments: Attend all scheduled visits; repeat ultrasound is usually done 4‑6 weeks after treatment to confirm resolution.
- Sexual activity: Abstain until your clinician clears you (typically after 7‑10 days of antibiotics and resolution of symptoms).
Emotional & Psychological Support
TOA can cause anxiety about fertility and sexual health. Consider:
- Speaking with a counselor or therapist.
- Joining support groups for women with PID/TOA.
- Educational resources from CDC and Planned Parenthood.
Prevention
- Safe sexual practices: Use condoms consistently and limit number of partners.
- Regular STI screening: At least annually for sexually active women under 25, or sooner after a new partner.
- Prompt treatment of PID: Early antibiotics reduce progression to TOA.
- Careful IUD insertion: Follow aseptic technique; schedule a post‑insertion check after 4‑6 weeks.
- Smoking cessation: Improves mucosal immunity.
- Manage chronic conditions: Good glucose control in diabetes lowers infection risk.
Complications
If a TOA is not treated promptly, complications can be severe:
- Rupture: Leads to generalized peritonitis and sepsis (mortality up to 5 % in severe cases).
- Infertility: Scarring of the fallopian tubes can impede conception; up to 30‑40 % of women develop tubal factor infertility after a TOA [3].
- Chronic pelvic pain: Persistent adhesions may cause long‑term discomfort.
- Abscess recurrence: 10‑20 % may develop a new TOA within 1 year.
- Fistula formation: Rarely, an abnormal connection (e.g., tubo‑vaginal or tubo‑cutaneous fistula) can develop.
- Sepsis and organ failure: Particularly in immunocompromised or elderly patients.
When to Seek Emergency Care
- Sudden, severe abdominal pain that worsens rapidly.
- High fever (≥39 °C / 102 °F) with chills.
- Rapid heartbeat (>120 bpm) or low blood pressure (≤90/60 mmHg).
- Vomiting that won’t stop, especially if you cannot keep fluids down.
- Signs of shock: dizziness, fainting, confusion, or cold, clammy skin.
- Noticeable swelling or a hard mass in the abdomen that grows quickly.
These symptoms may indicate a ruptured TOA or sepsis, which require urgent intravenous antibiotics, possible surgery, and intensive monitoring.
Sources:
- Mayo Clinic. “Tubo‑ovarian abscess.” https://www.mayoclinic.org. Accessed May 2026.
- Centers for Disease Control and Prevention. “Pelvic Inflammatory Disease (PID) Treatment Guidelines.” https://www.cdc.gov. 2023.
- World Health Organization. “Sexually transmitted infections (STIs): Fact sheet.” https://www.who.int. 2022.
- Cleveland Clinic. “Tubo‑ovarian abscess: Diagnosis and treatment.” https://my.clevelandclinic.org. 2024.
- National Institutes of Health. “Pelvic Inflammatory Disease.” https://www.nichd.nih.gov. 2023.